Open

2026/152: 2 R2A – Junior Postdoctoral Researchers

Ref. 2026_152

Call for applications for two R2A Junior Postdoctoral Researcher positions within the Complex Disease Genomics Research Group and the Pharmacogenomics and Stroke Genetics Research Group. Application deadline: 30 November 2026 at 3:00 p.m.

About the Project:

Methylation analyses and omics integration

We are seeking highly motivated and talented Postdoctoral Researchers wishing to further develop their scientific career in the area of Omics of Cardiovascular Disease to join our team in Institut de Recerca Sant Pau, Barcelona.

The postdoctoral researchers will work within the framework of the ambitious Horizon Europe project UNSOLVED-CARDS (Horizon-HLTH-2026-01-DISEASE-11), coordinated by our Institution, which explores shared and sex-specific mechanisms underlying cardiovascular diseases (CAD, stroke, and AAA) to develop targeted therapies and personalized risk prediction tools. We expect the selected Researchers to have a leading role in the project and its future publications.

We are looking for candidates to lead the methylome-wide analyses, examining the effects of methylation on large populations of cardiovascular disease patients. The successful applicant should be self-motivated, with the ability to work independently as well as in collaborative projects, have excellent written and oral communication skills, and be able to interact effectively and work productively in a team. We are particularly interested in candidates with a bioinformatics/statistics background who are well acquainted with data analysis and programming and are passionate about research in general and cardiovascular research in particular. Expertise in methylome analyses will be appreciated.

The position will be jointly hosted by the Genetics of Complex Disease and the Stroke Pharmacogenomics and Genetics groups and will be co-supervised by Dr Maria Sabater Lleal and Dr Israel Fernández Cadenas.

About the Research Groups

The Unit of Genomics of Complex Disease focuses its research activities on the acquisition, management, and analysis of multi-omics data, and their integration with clinical and biological data, with the aim of identifying novel biomarkers and developing risk prediction models to support clinical decision-making in patients with vascular diseases, including venous and arterial thrombosis and aneurysms.

The Neurovascular Pharmacogenomics and Genetics Group is a research team of 17 members dedicated to identifying new treatments and therapeutic targets through the use of multi-omics approaches, such as genome-wide association studies (GWAS), epigenome-wide association studies (EWAS), and proteomics. Their goal is to improve risk assessment and clinical outcomes in stroke and other neurological disorders.

Essential Requirements

  • PhD en Biotechnology, Biochemistry, Biomedicine, Bioinformatics, biostatistics, or related disciplines.
  • Demonstrated experience in omic analyses.
  • Expertise in R and Python programming and use of omic analytical tools.
  • Data management, critical thinking, and interpretation capacity.
  • Fluent in oral and written scientific English.

The following will be valued

  • Previous experience in epigenetic analyses.
  • Ability to work in a team.
  • Previous experience in collaborative research projects or consortia will be valued.

Duties

  • Organization and management of the database and biobanking of genomic and tissue samples.
  • Bioinformatic analysis of DNA methylation data through epigenome-wide association analyses (EWAS).
  • Multi-omic analysis, including genome-wide association studies (GWAS), proteomics, identification of methylation quantitative trait loci (meQTLs) and protein quantitative trait methylation (pQTM) analyses.
  • Sex stratification analyses.
  • Central role in project coordination and management.
  • Leading role in manuscript preparation, presentation at scientific conferences, and dissemination of research findings to broader audiences

We Offer

  • Permanent contract linked to the project: "Understanding Sex-Specific Omic Patterns Leading to Cardiovascular Disease Risk (UNSOLVED-CARDS)".
  • Annual working time of 1,627.5 hours, equivalent to 37.5 hours per week.
  • Retribution according to institutional salary scales.
  • Research Groups: Farmacogenomics and Neuravascular Genetics Group, and Unit of Genomics of Complex Disease

Application Procedure and Deadline

Interested candidates should preferably submit their documentation in PDF format by email to the Management of the Research Institute Foundation of Hospital de la Santa Creu i Sant Pau at seleccio@recercasantpau.cat, indicating reference 2026/152.

Required documentation

The deadline for submitting applications is 30 November 2026 at 3:00 p.m.

Apply to this offer

Accepted File Extensions: PDF, DOC, DOCX, ODT, TXT (max 10 MB)
Accepted File Extensions: PDF, DOC, DOCX, ODT, TXT (max 10 MB)
Text to Identify Refresh CAPTCHA